ARTICLE | Clinical News
MethylPatch: Phase III
April 8, 2002 7:00 AM UTC
In a placebo-controlled Phase III trial in about 200 children aged 6-12 with ADHD, MethylPatch significantly improved the primary endpoint of teacher ratings using the IOWA scale (p<0.001). In NOVN's ...